Patent applications published 1 June 2011
Selected patent applications from the weekly European Patents Bulletin
- Antimicrobial compsns and methods of use
Georgia State University 2326171*
- Antifungal agents
Merck Sharp & Dohme 2326172*
- HDAC4, HDAC5, HDAC6, HDAC7, and HIF1 alpha modulation of retinal cell survival
President and Fellows of Harvard College 2326174*
- Allosteric enhancers of the A1 adenosine receptor
King Pharmaceuticals Research & Development 2326175*
- Non-amidic linkers with branched termini as CGRP receptor antagonists
Merck Sharp & Dohme 2326176*
- 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists
Merck Sharp & Dohme 2326177*
- Prolyl hydroxylase inhibitors
GlaxoSmithKline 2326178*
- Prolyl hydroxylase inhibitors
SmithKline Beecham 2326179*
- Antifungal agents
Merck Sharp & Dohme; Scynexis 2326180*
- Anitfungal agents
Merck Sharp & Dohme; Scynexis 2326181*
- Medical devices employing conductive polymers for delivery of therapeutic agents
Boston Scientific Scimed 2326305*
- Liquid formulations of bendamustine
Cephalon 2326306*
- Crystalline active ingredient microparticles, method for producing the same, and use thereof in drugs
Jesalis Pharma 2326307*
- Improvements relating to pharmaceutical compsns
Iota NanoSolutions 2326308*
- Improvements relating to nanodisperse compsns
Iota NanoSolutions 2326309*
- Gastric retentive pharmaceutical compsns for treatment and prevention of CNS disorders
Depomed 2326310*
- Single unit oral dose pharmaceutical compsn comprising levodopa, cabidopa and entacapone or salts thereof
Wockhardt Research Centre 2326311*
- Paliperidone compsn comprising solid matrix particles
KRKA 2326312*
- pH-dependent controlled release pharmaceutical compsn for non-opioids with resistance against the influence of ethanol
Evonik Röhm 2326313*
- Particle compsns with pre-selected cell internalisation
Board of Regents of the University of Texas System 23226314*
- Treatment of an autoimmune disease using IL-18 antagonists
Glaxo Group 2326315*
- Sustained release compsns comprising gums and sugar alcohols
Avantor Performance Materials; Dumbre, Nilesh; Avachat, Amelia 2326316*
- Guanylhydrazones for treatment of postoperative intestinal inflammation
Cytokine Pharmasciences; Rheinische Friedrich-Wilhelms-Universität Bonn 2326317*
- Sur1 inhibitors for therapy
University of Maryland 2326318*
- Conjugated suramin amino compounds for medical conditions
Opiyo, Sammy 2326319*
- 2,4-disulphonyl pheny tert-butyl nitrone for the treatment of gliomas
Oklahoma Medical Research Foundation 2326320*
- Taurine of taurine-like substances for the prevention of brain odema
INSERM (Institut National de la Santé et de la Recherche Scientifique) 2326321*
- Novel crystal form of calcium-3-acetyl aminopropane1-sulphonate
Merck Patent 2326322*
- Compsns comprising terpene compounds for treating negative sensory phenomena
Neuroquest; Board of Supervisors of Louisiana University and Agriculture and Mechanical College 2326323*
- Use of dronedarone for the preparation of a medicament for the prevention of stroke of transient ischaemic attack
Sanofi-Aventis 2326324*
- Compounds for the treatment of peripheral neuropathies
Novartis 2326325*
- Purin derivatives for use in the treatment of FAB-related diseases
Boehringer Ingelheim International 2326326*
- Analogues of indole-3-carbinol and their use as agents against infection
SRI International 2326327*
- Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (SSAO) activity
Semmelweis Egyetem 2326328*
- Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
Wyeth 2326329*
- Compsns for treating or delaying the onset of hair loss
University of Central Florida Research Foundation 2326330*
- Novel lipid nanoparticles and novel components for delivery of nucleic acids
Merck Sharp & Dohme 2326331*
- Method for treatment of diseases
DMI Acquisition Corp 2326332*
- Agent for promoting neuronal differentiation and method therefor
Keio University 2326333*
- Method for treating bleeding disorders
Baxter Healthcare SA; Baxter International 2326334*
- Compsn for a tissue repair implant and methods of making the same
Lifenet Health 2326335*
- Tissue scaffolds derived from forestomach extracellular matrix
Mesynthes 2326336*
- Preparation for the treatment of the erectile disorder
Canali, Maria Grazia 2326337*
- A herbal formulation for prevention and treatment of diabetes and associated complications
Innoveda Biological Solutions 2326338*
- Methods for treating progressive cognitive disorders related to neurofibrillary tangles
Neurotez 2326339*
- Compsns and methods for treating S. Pneumoniae infection
Ben Gurion University of the Negev Research & Development Authority 2326340*
- Peptide formulations and uses thereof
Rijksuniversiteit Groningen 2326341*
- Methods for using interferon gamma to absorb fluid from the subretinal space
The United States of America, as represented by the Secretary, Department of Health and Human Services 2326342*